FDA
approval
· 2022-08-29
FDA Approved: OLMESARTAN MEDOXOMIL — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)
Summary
FDA approved a supplemental application for olmesartan medoxomil submitted by Glenmark Pharmaceuticals Inc., USA.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for OLMESARTAN MEDOXOMIL (OLMESARTAN MEDOXOMIL)